“Manipulating Stem Cell Fate” Featuring Dr. Shuibing Chen
On this episode of the Stem Cell Podcast, Dr. Shuibing Chen from Weill Cornell Medicine talks about using organoids to study diabetes, Zika, and SARS-CoV-2.
Dr. Shuibing Chen is the Kilts Family Professor of Surgery at Weill Cornell Medicine. Her lab uses hiPSCs and ESCs for disease modeling and drug screening, with a focus on diabetes and infectious diseases such as Zika and . She talks about , the role of philanthropic funding in stem cell research, and the role of industry partnerships in translational research.
Dr. Shuibing Chen is a stem cell biologist trained as an expert in pancreatic development, but she does a little bit of everything these days when it comes to disease modeling and drug screening. Her lab has been extremely productive in the last few years, using organoid models to study a variety of diseases ranging from cardiovascular disease to diabetes and even modeling COVID-19 in a dish!
Dr. Arun Sharma, host
Find more episodes at or wherever you get your podcasts.
This Episode's Stem Cell Roundup:
- – Scientists found that Hippo signaling is not needed for normal organ growth.
- – Researchers identified a subset of dysfunctional aged muscle stem cells with elevated levels of CD47.
- – Scientists used organoids to investigate how CHD7 mutations affect inner ear development.
- – Simultaneous hematopoietic cell and islet transplantation corrects diabetes in mice.
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
